CMS RBCS · Treatments · Injections and Infusions (nononcologic)

Injection - Somatostatin codes

2 CPT®/HCPCS codes, ranked by est. all-Medicare services — scaled from national Medicare Part B fee-for-service volume. Open any code for the full market view — ranked physician groups, geography, and 12-year trend.

CY2024 · National scale is an all-Medicare estimate · est. — scaled estimate — assumes MA utilization mirrors FFS; not an observation; the observed fee-for-service figure is shown adjacent. Part B · national figures

HCPCS · Treatment J1930 Injection, lanreotide, 1 mg CMS descriptor · HCPCS
Medicare Part B claims

First observed 2016 — first year this code appears in Part B claims

National scale 768,862 services · est. ▲ 25.8% YoY · 1,077 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 407,372 observed fee-for-service services

See the national market for J1930 → ranked groups · states · 12-yr trend

HCPCS · Treatment J2353 Injection, octreotide, depot form for intramuscular injection, 1 mg CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 33,446 services · est. ▼ 11.9% YoY · 183 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 17,060 observed fee-for-service services

See the national market for J2353 → ranked groups · states · 12-yr trend